IgG Index and Synthesis Rate
- Laboratory
- Labcorp
- Test code
- 203836
- Specimen
- Serum
- Fasting
- Not stated
- Turnaround
- 3 - 5 days
Labcorp test directory, test code 203836
Biomarkers · Chemical
We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.
Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.
Labcorp test directory, test code 203836
Laboratory assay overview
The IgG Synthesis Rate/Index is useful in diagnosing and monitoring patients with multiple sclerosis and other inflammatory diseases involving the brain and meninges.
See Laboratory Report
Quest Diagnostics test directory, test code 7558
0.8-7.7 mg/dL
Quest Diagnostics test directory, test code 4448
Laboratory assay overview
This test may be helpful in the evaluation of intrathecal synthesis of IgG in individuals with clinical suspicion of inflammatory diseases of the central nervous system (CNS), especially multiple sclerosis [1]. Intrathecal synthesis of IgG can be more specifically demonstrated by paring IgG/albumin ratios in the cerebrospinal fluid (CSF) and serum to calculate IgG index [2]. Elevated IgG levels in the CSF may be caused by increased intrathecal synthesis of IgG, increased permeability of blood-brain barrier, or both. Because albumin is not synthesized or metabolized in the CSF, it can be used to evaluate the permeability of the blood-CSF barrier. To demonstrate intrathecal synthesis of IgG specifically, IgG and albumin levels in the CSF and serum can be used to calculate IgG index [1]. In patients with multiple sclerosis, intrathecal synthesis of IgG may be evaluated with several assays. IgG/albumin ratio in the CSF may be elevated in about 70% of the patients. IgG index, calculated with paired IgG/albumin ratios in the CSF and serum, may be elevated in about 80% of patients. Oligoclonal bands may be detected in up to 95% of the patients [1-3]. Intrathecal synthesis of IgG may also be caused by other CNS inflammatory diseases, such as chronic meningoencephalitis, subacute sclerosing panencephalitis, and Guillain-Barre syndrome [1]. The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings. References 1. Johnson AM, et al. Amino acids, peptides, and proteins. In: Burtis CA, et al. eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th ed. Elsevier Inc; 2006:578-580. 2. Hershey LA, et al. Ann Neurol. 1980;8(4):426-434. 3. Giesser BS. Neurol Clin. 2011;29(2):381-388.
Quest Diagnostics population reference ranges
Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.
| Population | Range |
|---|---|
| IgG, CSF | 0.8-7.7 mg/dL |
| Albumin, CSF | 8.0-42.0 mg/dL |
| IgG/Albumin Ratio | <0.28 |
IgG, CSF | 0.8-7.7 mg/dL Albumin, CSF | 8.0-42.0 mg/dL IgG/Albumin Ratio | <0.28
Quest Diagnostics test directory, test code 39484
Laboratory assay overview
Detect and measure the level of IgG production by the central nervous system; has been applied to the diagnosis of multiple sclerosis along with CSF IgG synthesis rate and CSF immunoglobulin “oligoclonal” bands
Index: 0.0−0.7
Labcorp test directory, test code 002238
Laboratory assay overview
Evaluate the de novo rate of synthesis of IgG in CNS; diagnose inflammatory and autoimmune diseases involving CNS, in particular, multiple sclerosis; determine if IgG synthesis rate is based on the quotient of average normal serum IgG/average normal CSF IgG
Synthesis rate: -9.9 to +3.3 mg/24 hours
Labcorp test directory, test code 085928
Laboratory assay overview
Evaluate central nervous system involvement by infection, neoplasm, or primary neurologic disease (in particular, multiple sclerosis)
See table. Age Male (mg/dL) Female (mg/dL) 0 to 1 y Not established Not established 2 to 12 y 0.0−4.3 0.0−4.3 13 to 17 y 0.0−5.2 0.0−5.2 >17 y 0.0−10.3 0.0−6.7
Labcorp test directory, test code 012211
Labcorp test directory, test code 211003
Laboratory assay overview
This panel may be ordered to assist in the initial diagnosis and subsequent management of inflammatory, infectious, autoimmune, neoplastic, or other immune-mediated disorders affecting the nervous system. Quantitative values for IgM, IgG, and IgA will be reported [1]. Immunoglobulins, or antibodies, are proteins made by the immune system in response to an infection or other potential threat. Immunoglobulins come in various forms (IgM, IgG, IgA, and others) and have unique properties and functions to coordinate the body’s response [1]. A serum-based immunoglobulin panel (test code 7083) can also be used to evaluate conditions associated with abnormal immunoglobulin levels; however, this test, which uses CSF as the sample is preferred if there is clinical suspicion of multiple sclerosis (MS). About 80% of patients with MS have elevated IgG antibody levels in their CSF, making this test useful for diagnosis [2]. This test should be interpreted in the context of pertinent clinical and family history and physical examination findings. References 1. Burtis C, et al. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. St Louis, Missouri: Elsevier; 2015:310-314. 2. National Institutes of Health. CSF immunoglobulins G (IgG) index. https://medlineplus.gov/lab-tests/csf-immunoglobulin-g-igg-index/. Last updated June 27, 2018. Accessed January 14, 2020.
See individual tests
Quest Diagnostics test directory, test code 6705
Laboratory assay overview
Adjunct in aiding clinical diagnosis of multiple sclerosis
Labcorp test directory, test code 123075
Laboratory assay overview
Adjunct in aiding clinical diagnosis of multiple sclerosis
Labcorp test directory, test code 123390
We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.
Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.